key: cord-0939995-ao1pcw6w
authors: Ai, Sylvia; Awford, Alexander; Roncolato, Fernando
title: Hemophagocytic lymphohistiocytosis following ChAdOx1 nCov‐19 vaccination
date: 2021-08-23
journal: J Med Virol
DOI: 10.1002/jmv.27279
sha: 7a34ec768931f83f6e692de95288bdb078cbd012
doc_id: 939995
cord_uid: ao1pcw6w

Hemophagocytic lymphohistiocytosis (HLH) is a disorder of excessive inflammation and tissue destruction characterised by a hyperinflammatory immune state. We present the first described case of HLH precipitated by the ChAdOx1 nCov-19 vaccine in a 68 year old man who developed fevers, rigors and night sweats 13 days following ChAdOx1 nCov-19 vaccination. This article is protected by copyright. All rights reserved.

To the Editor,

The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the resulting pandemic has led to the rapid production of several vaccines with more than 1.4 billion doses provided to date. 1 Although serious adverse events have remained uncommon, the ChAdOx1 nCov-19 vaccine, a recombinant chimpanzee adenoviral vector encoding the spike protein of SARS-CoV-2, has been associated with thrombotic thrombocytopenia syndrome. 2 We present the first case of hemophagocytic lymphohistiocytosis (HLH) precipitated by the ChAdOx1 nCov-19 vaccine. however, these diagnostic criteria were developed for children and are not validated formally in adults. The H-score is a diagnostic scoring system for HLH developed for adults based on clinical, biologic, and cytologic parameters. 5 Our patient's H-score is 250, which is associated with a more than 99% probability of having HLH.

In randomized controlled trials of the ChAdOx1 vaccine, the most common side effects reported were injection-site pain and F I G U R E 1 Bone marrow aspirate demonstrating evidence of hemophagocytosis

World Health Organisation. WHO coronavirus (COVID-19) dashboard

Thrombosis and thrombocytopenia after ChAdOx1 nCoV-19 vaccination

Histiocytic disorders: recent insights into pathophysiology and practical guidelines

HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer

Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

Guillain-Barre syndrome following the first dose of the chimpanzee adenovirus-vectored COVID-19 vaccine, ChAdOx1

Haemophagocytic syndrome and COVID-19

Hemophagocytic lymphohistiocytosis after COVID-19 vaccination

Immunophenotypic attributes of benign peripheral blood gammadelta T cells and conditions associated with their increase

18-FDG PET/CT findings in hemophagocytic lymphohistiocytosis: a pictorial review